PR: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement for the Development of Antibody Drug Conjugates
- PDF File: images/files/press-releases-and-ad-hoc-announcements/20180305_pr_hdp_magenta_adc-kooperation_engl-final.pdf
- Datum: Monday, 05 March 2018 15:18
- Erstellt am .
- Geändert am .
- Aufrufe: 1292